Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
29°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Spero Therapeutics Inc
(NQ:
SPRO
)
1.175
-0.015 (-1.26%)
Streaming Delayed Price
Updated: 3:57 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Spero Therapeutics Inc
< Previous
1
2
3
4
5
Next >
Earnings Scheduled For November 14, 2024
November 14, 2024
Via
Benzinga
Spero Therapeutics's Earnings Outlook
November 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 30, 2024
Via
Benzinga
Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
October 30, 2024
Via
Benzinga
SPRO Stock Earnings: Spero Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 05, 2024
SPRO stock results show that Spero Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
3 Micro-Cap Moonshots for Fearless Investors
July 08, 2024
Investors should know the risks of micro-cap stocks before looking into these three high-potential companies with low prices.
Via
InvestorPlace
Recap: Spero Therapeutics Q4 Earnings
March 13, 2024
Via
Benzinga
Earnings Outlook For Spero Therapeutics
March 12, 2024
Via
Benzinga
Recap: Spero Therapeutics Q3 Earnings
November 13, 2023
Via
Benzinga
SPRO Stock Earnings: Spero Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 15, 2024
SPRO stock results show that Spero Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 14, 2024
Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates.
Via
Benzinga
Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
March 14, 2024
Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) rose sharply in today’s pre-market trading after the company reported February trading metrics.
Via
Benzinga
Earnings Outlook For Spero Therapeutics
November 10, 2023
Via
Benzinga
4 Analysts Have This to Say About Spero Therapeutics
September 05, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 14, 2024
It's time to start the day with a breakdown of all the biggest pre-market stock movers worth watching on Thursday morning!
Via
InvestorPlace
Earnings Scheduled For March 13, 2024
March 13, 2024
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
Via
Benzinga
Spero Therapeutics's Earnings: A Preview
August 09, 2023
Via
Benzinga
Recap: Spero Therapeutics Q1 Earnings
May 11, 2023
Via
Benzinga
Spero Therapeutics's Earnings Outlook
May 10, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
December 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 13, 2023
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
September 18, 2023
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Spero Therapeutics: Here's What You Need To Know
August 14, 2023
Via
Benzinga
Spero Therapeutics's Earnings: A Preview
March 29, 2023
Via
Benzinga
Earnings Scheduled For November 13, 2023
November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
Via
Benzinga
Earnings Scheduled For August 10, 2023
August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Via
Benzinga
Earnings Scheduled For May 11, 2023
May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 31, 2023
It's time for another dive into the biggest pre-market stock movers with all the hot topics traders need to know about on Friday!
Via
InvestorPlace
Earnings Scheduled For March 30, 2023
March 30, 2023
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.